Bafna Pharmaceuticals standalone net profit declines 32.35% in the September 2022 quarter
Sales decline 22.78% to Rs 21.96 crore
Net profit of Bafna Pharmaceuticals declined 32.35% to Rs 1.61 crore in the quarter ended September 2022 as against Rs 2.38 crore during the previous quarter ended September 2021. Sales declined 22.78% to Rs 21.96 crore in the quarter ended September 2022 as against Rs 28.44 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales21.9628.44 -23 OPM %11.5720.04 -PBDT2.735.77 -53 PBT1.614.35 -63 NP1.612.38 -32Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 11 2022 | 4:03 PM IST